Toquiantzi AMA, Ramírez BM

Language: Spanish
References: 21
Page: 304-306
PDF size: 225.55 Kb.

ABSTRACT

The most frequent cause of mortality worldwide is due to coronary heart disease; Therefore, early diagnosis and treatment of acute myocardial infarction is necessary. High-sensitivity troponins are the cardiac biomarkers with the best negative predictive value (95%), therefore they facilitate the early exclusion of acute myocardial infarction with the aim of reducing hospital stay and death. Troponins are a tool that facilitates clinical decision-making in patients with chest pain, so implementing protocols will facilitate decision-making as they will allow us to better stratify the risk beyond a definitive diagnosis. However, the big problem is of these studies is the lack of clinical judgment, considering that the degree of recommendation must be improved, it is appropriate to consider the use of risk scores according to the guidelines of each workplace. Before applying a protocol in your hospital, it is important to know the troponin used in your central laboratory.

REFERENCES

1. Steg G, James SK, Atar D, Badano LP, et al. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST. Rev Esp Cardiol. 2013;66(1):53.e1-e46.

2. Thygesen K, Alpert JS, Jaffe AS, et al. Consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio. Rev Esp Cardiol. 2019;72(1):72.e1-e27.

3. Hollander JE, Than M, Mueller C. State-of-the-Art evaluation of emergency department patients presenting with potential acute coronary syndromes. Circulation. 2016;134(7):547-564.

4. Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG, et al. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017; 12:147-155.

5. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kübler W. Enzyme linked immuno assay of cardiac troponin T BNfor the detection of acute myocardial infarction in patients. J Mol Cell Cardiol. 1989;21(12):1349-1353.

6. Jaffe AS, Landt Y, Parvin CA, Abendschein DR, Geltman EM, Ladenson JH. Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosing acute myocardial infarction. Clin Chem. 1996;42(11):1770-1776.

7. Balk EM, Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med. 2001;37(5):478-494.

8. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361(9):858-867.

9. Carlton EW, Cullen L, Than M, Gamble J, Khattab A, Greaves K. A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart. 2015;101(13):1041-1046.

10. Weber M, Bazzino O, Navarro-Estrada JL, de Miguel R, Salzberg S, Fuselli JJ, et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J. 2011;162(1):81-88.

11. Shah AS, Newby DE, Mills NL. High sensitivity cardiac troponin in patients with chest pain. BMJ. 2013;347:f4222.

12. Chiang CH, Chiang CH, Lee GH, Gi WT, Wu YK, Huang SS, et al. Safety and efficacy of the European Society of Cardiology 0/1-hour algorithm for diagnosis of myocardial infarction: systematic review and meta-analysis. Heart. 2020;106(13):985-991.

13. Badertscher P, Boeddinghaus J, Twerenbold R, Nestelberger T, Wildi K, Wussler D, et al. Direct comparison of the 0/1h and 0/3h algorithms for early rule-out of acute myocardial infarction. Circulation. 2018;137(23):2536-2538.

14. McCarthy CP, Raber I, Chapman AR, Sandoval Y, Apple FS, Mills NL, et al. Myocardial injury in the era of high-sensitivity cardiac troponin assays: a practical approach for clinicians. JAMA Cardiol. 2019;4(10):1034-1042.

15. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335(18):1342-1349.

16. Azar RR, Sarkis A, Giannitsis E. A practical approach for the use of high-sensitivity cardiac troponin assays in the evaluation of patients with chest pain. Am J Cardiol. 2021;139:1-7.

17. Arslan F, Damman P, Zwart B, Appelman Y, Voskuil M, de Vos A, et al. 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation: recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups. Neth Heart J. 2021;29(11):557-565.

18. Andruchow JE, Kavsak PA, McRae AD. Contemporary emergency department management of patients with chest pain: a concise review and guide for the high-sensitivity troponin era. Can J Cardiol. 2018;34(2):98-108.

19. Neumann JT, Twerenbold R, Ojeda F, Sorensen NA, Chapman AR, Shah ASV, et al. Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med. 2019;380(26):2529-2540.

20. Januzzi JL Jr, McCarthy CP. Evaluating chest pain in the emergency department: searching for the optimal gatekeeper. J Am Coll Cardiol. 2018;71(6):617-619.

21. Nerenberg RH, Shofer FS, Robey JL, Brown AM, Hollander JE. Impact of a negative prior stress test on emergency physician disposition decision in ED patients with chest pain syndromes. Am J Emerg Med. 2007;25(1):39-44.